Association for Accessible Medicines: Amneal Announces U.S. Expansion of End-to-End Biosimilars Development With Acquisition of Kashiv BioSciences
August 22, 2026
August 22, 2026
WASHINGTON, Aug. 22 -- The Association for Accessible Medicines issued the following news release on Aug. 21, 2026:
* * *
Amneal Announces U.S. Expansion of End-to-End Biosimilars Development With Acquisition of Kashiv BioSciences
Adds Chicago research and development facility, New Jersey manufacturing site
-
The Association for Accessible Medicines today commented on the announcement by Amneal Pharmaceuticals, Inc. of the completi . . .
* * *
Amneal Announces U.S. Expansion of End-to-End Biosimilars Development With Acquisition of Kashiv BioSciences
Adds Chicago research and development facility, New Jersey manufacturing site
-
The Association for Accessible Medicines today commented on the announcement by Amneal Pharmaceuticals, Inc. of the completi . . .
